Comprehensive analytics for viral vectors, plasmids, and transgenes using advanced nanopore long read technology.
Faster QC turnaround
Accelerate your gene therapy development with rapid, reliable quality data.
Serving biotech leaders with advanced nanopore-based quality control for viral vectors, plasmids, and transgenes.
Comprehensive analytics for viral vectors, plasmids, and transgenes. Ensure regulatory compliance and product integrity with advanced nanopore sequencing.
Sequencing accuracy achieved with our nanopore long read technology, supporting robust quality control for gene therapy products.
Continuous monitoring and rapid turnaround times for all quality control projects, ensuring timely delivery of critical data.
Detect structural variants, sequence errors, and contaminants in plasmid preparations to meet regulatory standards.
Confirm transgene identity, sequence fidelity, and integration status for reliable gene therapy development.
“Qcellect delivered precise, data-driven analysis of our viral vector quality. Their nanopore sequencing expertise ensured our gene therapy products consistently met regulatory standards for safety and efficacy. The team’s objective reporting improved our process reliability and streamlined compliance documentation.”